Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 30, Issue 6, Pages 1139-1151
Publisher
Informa Healthcare
Online
2014-02-17
DOI
10.1185/03007995.2014.894501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs
- (2012) Marko Obradovic et al. CLINICAL THERAPEUTICS
- Non-Analgesic Effects of Opioids: Factors Relevant to Opioid Abuse and Abuse- Deterrent Formulations
- (2012) Joseph V. Pergolizzi et al. CURRENT PHARMACEUTICAL DESIGN
- Non-Analgesic Effects of Opioids: Opioid-induced Nausea and Vomiting: Mechanisms and Strategies for their Limitation
- (2012) Flaminia Coluzzi et al. CURRENT PHARMACEUTICAL DESIGN
- Non-Analgesic Effects of Opioids: Management of Opioid-Induced Constipation by Peripheral Opioid Receptor Antagonists: Prevention or Withdrawal?
- (2012) Peter Holzer CURRENT PHARMACEUTICAL DESIGN
- Opioid-Induced Bowel Dysfunction
- (2012) Christina Brock et al. DRUGS
- Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States
- (2012) Nancy Neil et al. JOURNAL OF MEDICAL ECONOMICS
- Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis
- (2012) William Dunlop et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
- (2012) Robert Ikenberg et al. JOURNAL OF MEDICAL ECONOMICS
- Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
- (2011) Michael Camilleri AMERICAN JOURNAL OF GASTROENTEROLOGY
- The prevalence, correlates and treatment of pain in the European Union
- (2011) P.C. Langley CURRENT MEDICAL RESEARCH AND OPINION
- The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors?
- (2011) Joseph Pergolizzi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain
- (2010) Bernd Lange et al. ADVANCES IN THERAPY
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee
- (2010) Marc Afilalo et al. CLINICAL DRUG INVESTIGATION
- Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
- (2010) Robert Buynak et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Direct and Indirect Costs of Opioid-Induced Constipation
- (2010) Frida Hjalte et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain
- (2010) James E. Wild et al. Pain Practice
- The impact of pain on labor force participation, absenteeism and presenteeism in the European Union
- (2010) Paul Langley et al. JOURNAL OF MEDICAL ECONOMICS
- Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial
- (2009) O Löwenstein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain
- (2008) K. Simpson et al. CURRENT MEDICAL RESEARCH AND OPINION
- A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation
- (2008) Winfried Meissner et al. EUROPEAN JOURNAL OF PAIN
- Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain
- (2008) Dana Vondrackova et al. JOURNAL OF PAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now